Evidence map›Paper›PMID 25862703›Full record

Trial reportHaematologica2015

Repeat course of rabbit antithymocyte globulin as salvage following initial therapy with rabbit antithymocyte globulin in acquired aplastic anemia.

Diego V Clé, Elias H Atta, Danielle S P Dias, Carlos B L Lima, Mariana Bonduel, Gabriela Sciuccati, Larissa A Medeiros, Michel M de Oliveira, Marco A Salvino, Marlene Garanito and 3 more

Open access · goldAbstract readClinical TrialLetter
In one paragraph

Trial report in Haematologica, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. [How I treat refractory sever aplastic anemia].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2020
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 3 countries.

Diego V CléDivision of Hematology, University of São Paulo at Ribeirão Preto School of Medicine, Ribeirão Preto, Brasil dvcle@hcrp.usp.br.
Elias H AttaCEMO, National Cancer Institute, Rio de Janeiro, Brasil.
Danielle S P DiasHematopoietic Stem Cell Program, Hemorio, Rio de Janeiro, Brasil.
Carlos B L LimaHematopoietic Stem Cell Program, Hemorio, Rio de Janeiro, Brasil.
Mariana BonduelServicio de Hematología-Oncología, Hospital de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina.
Gabriela SciuccatiServicio de Hematología-Oncología, Hospital de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina.
Larissa A MedeirosBone Marrow Transplantation unit, Federal University of Paraná, Curitiba, Brasil.
Michel M de OliveiraBone Marrow Transplantation unit, Federal University of Paraná, Curitiba, Brasil.
Marco A SalvinoBone Marrow Transplantation unit, Federal University of Bahia, Salvador.
Marlene GaranitoChild's Institute, University of São Paulo, Brasil.
Sara T Ollala SaadNational Institute of Science and Technology of Blood, University of Campinas, Brasil.
Rodrigo T CaladoDivision of Hematology, University of São Paulo at Ribeirão Preto School of Medicine, Ribeirão Preto, Brasil.
Phillip ScheinbergDivision of Hematology, University of São Paulo at Ribeirão Preto School of Medicine, Ribeirão Preto, Brasil Clinical Hematology, Antônio Ermírio de Moraes Cancer Center, Hospital São José e Beneficência Portuguesa, São Paulo, Brasil.
Universidade de São Paulo · BRGarrahan Hospital · ARHemorio · BRUniversidade Federal do Paraná · BRInstituto Nacional do Câncer · BRUniversidade Estadual de Campinas (UNICAMP) · BRUniversidade Federal da Bahia · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Salvage TherapyAnemia, AplasticAnimalsAntilymphocyte SerumDisease-Free SurvivalFemaleHumansImmunologic FactorsMaleRabbitsSurvival RateAntilymphocyte SerumImmunologic Factorsexpression levelslymphomamantle cell lymphomaSOX11

Identifiers

PMID25862703
PMCPMC4800686
OpenAlexW2096569947

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.